Sfoglia per Rivista  CANCER

Opzioni
Vai a: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Mostrati risultati da 1 a 20 di 53
Titolo Data di pubblicazione Autore(i) File
Allogeneic hematopoietic stem cell transplantation as part of postremission therapy improves survival for adult patients with high-risk acute lymphoblastic leukemia: a meta-analysis 2007 BARTOLOZZI B; A. BOSI; ORSI C
Breast-conserving therapy for Paget disease of the nipple: a prospective European Organization for Research and Treatment of Cancer study of 61 patients 2001 BIJKER N.; RUTGERS E.J; DUCHATEAU L.; PETERSE J.L; JULIEN J.P.; L. CATALIOTTI
CLINICAL DIAGNOSIS AND THERAPY OF CUTANEOUS MELANOMA IN SITU 1996 D. MASSI
Combined chemotherapy with carmustine, doxorubicin, etoposide, vincristine, and cyclophosphamide plus mitoxantrone, cytarabine and methotrexate with citrovorum factor for the treatment of aggressive non-Hodgkin lymphoma. 2005 RIGACCI L; CARRAI V; NASSI L; ALTERINI R; LONGO G; BERNARDI F; A. BOSI
Comparison of anastrozole versus tamoxifen as preoperative therapy in postmenopausal women with hormone receptor-positive bresat cancer:the preoperative "Arimidex" compared to Tamoxifen (PROACT) trial. 2006 L. CATALIOTTI; BUZDAR AU; NOGUCHI S; BINES J; TAKATSUKA Y; PETRAKOVA K; DUBE P; TOSELLO DE OLIVEIRA C
Complex karyotype is a stronger predictor than del(17p) for an inferior outcome in relapsed or refractory chronic lymphocytic leukemia patients treated with ibrutinib-based regimens 2015 Thompson, Philip A; O'Brien, Susan M.; Wierda, William G.; Ferrajoli, Alessandra; Stingo, Francesco; Smith, Susan C.; Burger, Jan A.; Estrov, Zeev; Jain, Nitin; Kantarjian, Hagop M.; Keating, Michael J.
Congenital hypertrophy of the retinal pigment epithelium in familial adenomatous polyposis: novel criteria of assesment and correlations with constitutional adenomatous polyposis coli gene mutations. 1996 R. VALANZANO; CAMA A.; VOLPE R.; CURIA MC.; MENCUCCI R.
Consensus Conference on the treatment of in situ ductal carcinoma of the breast April 22-25 1999 2000 SCHWARTZ G.F.; SOLIN L.J.; OLIVOTTO I.A.; THE CONSENSUS CONFERENCE COMMITTEE; L. CATALIOTTI
Continued azacitidine therapy beyond time of first response improves quality of response in patients with higher-risk myelodysplastic syndromes. 2011 L.R. Silverman ; P.Fenaux ; G.J.Mufti ; V.Santini ; E.Hellström-Lindberg ; N.Gattermann ; G. Sanz ; A.F. List ; S.D.Gore ; J.F. Seymour
Cytopathological diagnosis in a cancer registry: a useful diagnostic tool? 2007 Caldarella A.; Crocetti E.; Taddei G.L.; Paci E.
CYTOTOXIC/NATURAL KILLER CELL CUTANEOUS LYMPHOMAS: REPORT OF THE E.O.R.T.C. CUTANEOUS LYMPHOMA TASK FORCE WORKSHOP. 2003 M. SANTUCCI; N. PIMPINELLI; D. MASSI; M.E. KADIN; C.J.L.M. MEIJER; H.K. MULLER-HERMELINK; M. PAULLI; J. WECHSLER; R. WILLEMZE; H. AUDRING; M.G. BERNENGO; L. CERRONI.
Efficacy of imatinib dose escalation in patients with chronic myeloid leukemia in chronic phase. 2009 Kantarjian HM; Larson RA; Guilhot F; O'Brien SG; Mone M; Rudoltz M; Krahnke T; Cortes J; Druker BJ; International Randomized Study of Interferon and STI571 (IRIS) Investigators. Durant S; Schwarer A; Joske D; Seymour J; Grigg A; Ma D; Arthur C; Bradstock K; Joshua D; Louwagi A; Martiat P; Bosly A; Shistok C; Lipton J; Forrest D; Walker I; Roy DC; Rubinger M; Bence-Bruckler I; Stewart D; Kovacs M; Turner AR; Birgens H; Bjerrum O; Facon T; Harousseau JL; Tulliez M; Guerci A; Blaise D; Maloisel F; Michallet M; Andreesen R; Nerl C; Freund M; Gattermann N; Ehninger G; Deininger M; Ottmann O; Peschel C; Fruehauf S; Neubauer A; le Coutre P; Aulitzky W; Fanin R; Rosti G; Mandelli F; Lazzarino M; Morra E; Carella A; Petrini M; Nobile F; Liso V; Ferrara F; Rizzoli V; Fiortoni G; Martinelli G; Ossenkoppele G; Browett P; Gedde-Dahl T; Tangen JM; Dahl I; Odrizoala J; Hernandez Boulda JC; Steegman JL; Canizo C; Diaz J; Grenena A; Fernandez MN; Stenke L; Paul C; Bjoreman M; Malm C; Wadenvik H; Nilsson PG; Turesson I; Hess U; Solenthaler M; Clark RE; Green AR; Holyoake TL; Lucas GS; Smith G; Milligan DW; Rule SJ; Burnett AK; Moroose R; Wetzler M; Bearden J; Cataland S; Robinowitz I; Meisenberg B; Thompson K; Graziano S; Emanuel P; Gross H; Cobb P; Bhatia R; Dakhil S; Irwin D; Issell B; Pavletic S; Kuebler P; Layhe E; Butra P; Glass J; Moore J; Grant B; Neill H; Herzig R; Burris H; Petersen B; Kalaycio M; Stirewalt D; Samlowski W; Berman E; Limentani S; Seay T; Shea T; Akard L; Smith G; Becker P; Devine S; Hart R; Veith R; Wade J; Brunvad M; Kalman L; Strickland D; Shurafa M; Bashey A; Shadduck R; Safah H; Rubenstein M; Collins R; Keller A; Tallman M; Pecora A; Agha M; Homes H; Guidice R; Santini V. Kantarjian HM; Larson RA; Guilhot F; O'Brien SG; Mone M; Rudoltz M; Krahnke T; Cortes J; Druker BJ; International Randomized Study of Interferon and STI571 (IRIS) Investigators. Durant S; Schwarer A; Joske D; Seymour J; Grigg A; Ma D; Arthur C; Bradstock K; Joshua D; Louwagi A; Martiat P; Bosly A; Shistok C; Lipton J; Forrest D; Walker I; Roy DC; Rubinger M; Bence-Bruckler I; Stewart D; Kovacs M; Turner AR; Birgens H; Bjerrum O; Facon T; Harousseau JL; Tulliez M; Guerci A; Blaise D; Maloisel F; Michallet M; Andreesen R; Nerl C; Freund M; Gattermann N; Ehninger G; Deininger M; Ottmann O; Peschel C; Fruehauf S; Neubauer A; le Coutre P; Aulitzky W; Fanin R; Rosti G; Mandelli F; Lazzarino M; Morra E; Carella A; Petrini M; Nobile F; Liso V; Ferrara F; Rizzoli V; Fiortoni G; Martinelli G; Ossenkoppele G; Browett P; Gedde-Dahl T; Tangen JM; Dahl I; Odrizoala J; Hernandez Boulda JC; Steegman JL; Canizo C; Diaz J; Grenena A; Fernandez MN; Stenke L; Paul C; Bjoreman M; Malm C; Wadenvik H; Nilsson PG; Turesson I; Hess U; Solenthaler M; Clark RE; Green AR; Holyoake TL; Lucas GS; Smith G; Milligan DW; Rule SJ; Burnett AK; Moroose R; Wetzler M; Bearden J; Cataland S; Robinowitz I; Meisenberg B; Thompson K; Graziano S; Emanuel P; Gross H; Cobb P; Bhatia R; Dakhil S; Irwin D; Issell B; Pavletic S; Kuebler P; Layhe E; Butra P; Glass J; Moore J; Grant B; Neill H; Herzig R; Burris H; Petersen B; Kalaycio M; Stirewalt D; Samlowski W; Berman E; Limentani S; Seay T; Shea T; Akard L; Smith G; Becker P; Devine S; Hart R; Veith R; Wade J; Brunvad M; Kalman L; Strickland D; Shurafa M; Bashey A; Shadduck R; Safah H; Rubenstein M; Collins R; Keller A; Tallman M; Pecora A; Agha M; Homes H; Guidice R; Santini V.
EPITHELIAL OVARIAN TUMORS IN THE REPRODUCTIVE AGE GROUP: AGE IS NOT AN INDEPENDENT PROGNOSTIC FACTOR 1996 D. MASSI; T. SUSINI; L. SAVINO; V. BODDI; G. AMUNNI; M. COLAFRANCESCHI.
Expression of matrix metalloproteinase 1, matrix metalloproteinase 2, and matrix metalloproteinase 9 in carcinoma of the head and neck 2002 A. FRANCHI; M. SANTUCCI; E. MASINI; I. SARDI; M. PAGLIERANI; O. GALLO
Gastric cancer in a high-risk area in Italy: Histopathologic patterns according to Lauren's classification 1988 Amorosi; A.; Bianchi; S.; Buiatti; E.; Cipriani; F.; Palli; D.; Zampi; G.
Gemcitabine as frontline treatment for cutaneous T-cell lymphoma: phase II study of 32 patients. 2005 Marchi E;Alinari L;Tani M;Stefoni V;Pimpinelli N;Berti E;Pagano L;Bernengo MG;Zaja F;Rupoli S;Pileri S;Baccarani M;Zinzani PL
Gender differences in non-small cell lung cancer: a population-based study 2007 CALDARELLA A; CROCETTI E; C. COMIN; JANNI A; PEGNA AL; PACI E
Genetic alterations between primary head and neck squamous cell carcinoma and recurrence after radiotherapy 2010 A.Deganello; A.Franchi; I.Sardi; L.Pignataro; CR. Leemans; O.Gallo
Homoharringtonine: history, current research, and future direction. 2001 KANTARJIAN HM; TALPAZ M; V. SANTINI; MURGO A; CHESON B; O'BRIEN SM.
Improving the reproducibility of diagnosing micrometastases and isolated tumor cells. 2005 G. CSERNI; S. BIANCHI; W. BOECKER ET AL
Mostrati risultati da 1 a 20 di 53
Legenda icone

  •  file ad accesso aperto
  •  file disponibili sulla rete interna
  •  file disponibili agli utenti autorizzati
  •  file disponibili solo agli amministratori
  •  file sotto embargo
  •  nessun file disponibile